Showing 1 - 20 results of 48 Refine Results
  1. 1
    Academic Journal

    Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

    Authors: James L Gulley, Elad Sharon, Julius Strauss, Steven P Fling, Anna Wright, Teresa Moran, Kathryn Lurain, Ramya Ramaswami, Thomas S Uldrick, Robert Yarchoan, Maria Gonzalez-Cao, Javier Martinez-Picado, Thomas A Odeny

    Source: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)

    Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://jitc.bmj.com/content/10/9/e005128.full; https://doaj.org/toc/2051-1426

    Access URL: https://doaj.org/article/040ee9ed4fc648b5b5356b0d33884972

    Find It @ SCU Libraries View record from DOAJ
    Save to List
  2. 2
    Academic Journal

    Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

    Authors: Mariano Provencio, Josefa Terrasa, Pilar Garrido, Rosario García Campelo, Francisco Aparisi, Pilar Diz, David Aguiar, Carlos García-Giron, Julia Hidalgo, Carlos Aguado, Jorge García González, Emilio Esteban, Lorenzo Gómez-Aldavarí, Teresa Moran, Oscar Juan, Luís Enrique Chara, Juan L. Marti, Rafael López Castro, Ana Laura Ortega, Elia Martínez Moreno, Juan Coves, Ana M. Sánchez Peña, Joaquim Bosch-Barrera, Amparo Sánchez Gastaldo, Natalia Fernández Núñez, Edel del Barco, Manuel Cobo, Dolores Isla, Margarita Majem, Fátima Navarro, Virginia Calvo

    Source: BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)

    Subject Terms: Osimertinib, Real-world data, EGFR-activating mutations, T790M EGFR mutation, Second line, Non-small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    Access URL: https://doaj.org/article/8ebc0e8ffdc84091be87e3c5b709643d

    Find It @ SCU Libraries View record from DOAJ
    PDF Full Text
    Save to List
  3. 3
    Academic Journal

    Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics

    Authors: Carmen Balana, Sara Castañer, Cristina Carrato, Teresa Moran, Assumpció Lopez-Paradís, Marta Domenech, Ainhoa Hernandez, Josep Puig

    Source: Frontiers in Neurology, Vol 13 (2022)

    Subject Terms: glioma, glioblastoma, radiomics, radiogenomics, liquid biopsy, diagnosis, Neurology. Diseases of the nervous system, RC346-429

    File Description: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fneur.2022.865171/full; https://doaj.org/toc/1664-2295

    Access URL: https://doaj.org/article/0f9ce293924c47539a075523775161b8

    Find It @ SCU Libraries View record from DOAJ
    Save to List
  4. 4
    Academic Journal

    Lung cancer symptoms at diagnosis: results of a nationwide registry study

    Authors: Maria Sala, Ana Laura Ortega Granados, Virginia Calvo de Juan, Teresa Moran, Delvys Rodriguez-Abreu, Rafael López-Castro, Eugenio Cuadrado Albite, María Guirado, Lucía Gómez González, Ana Blasco, Manuel Cobo, Rosario Garcia-Campelo, Joaquim Bosch, José Trigo, Óscar Juan, Carlos Aguado de la Rosa, Manuel Dómine, Juana Oramas, Joaquín Casal-Rubio, Sara Cerezo

    Source: ESMO Open, Vol 5, Iss 6 (2020)

    Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://esmoopen.bmj.com/content/5/6/e001021.full; https://doaj.org/toc/2059-7029

    Access URL: https://doaj.org/article/fb04a993644146dfb25df3c66b954387

    View record from ScienceDirect Find It @ SCU Libraries View record from DOAJ
    Linked Full Text
    Save to List
  5. 5
    Academic Journal

    Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

    Authors: Rafael Rosell, Laia Perez-Roca, Jose Javier Sanchez, Manuel Cobo, Teresa Moran, Imane Chaib, Mariano Provencio, Manuel Domine, Maria Angeles Sala, Ulpiano Jimenez, Pilar Diz, Isidoro Barneto, Jose Antonio Macias, Ramon de Las Peñas, Silvia Catot, Dolores Isla, Jose Miguel Sanchez, Rafael Ibeas, Guillermo Lopez-Vivanco, Juana Oramas, Pedro Mendez, Noemi Reguart, Remei Blanco, Miquel Taron

    Source: PLoS ONE, Vol 4, Iss 5, p e5133 (2009)

    Subject Terms: Medicine, Science

    File Description: electronic resource

    Relation: http://europepmc.org/articles/PMC2673583?pdf=render; https://doaj.org/toc/1932-6203

    Access URL: https://doaj.org/article/8df183c3cfa54251ba5c08c80b585cbf

    Find It @ SCU Libraries View record from DOAJ
    PDF Full Text
    Save to List
  6. 6
    Academic Journal

    ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

    Authors: Alexandra Leary, Purificación Estévez-García, Renaud Sabatier, Isabelle Ray-Coquard, Margarita Romeo, Pilar Barretina-Ginesta, Marta Gil-Martin, Elena Garralda, Joaquim Bosch-Barrera, Teresa Morán, Paloma Martin-Martorell, Ernest Nadal, Pere Gascón, Jordi Rodon, Jose M Lizcano, Pau Muñoz-Guardiola, Gemma Fierro-Durán, Oriol Pedrós-Gámez, Héctor Pérez-Montoyo, Marc Yeste-Velasco, Marc Cortal, Antonio Pérez-Campos, Jose Alfon, Carles Domenech, Alejandro Pérez-Fidalgo, Ana Oaknin

    Source: BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)

    Subject Terms: Endometrial cancer, Autophagy, Chemotherapy, Phase 1/2, Safety profile, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    Access URL: https://doaj.org/article/e9af8aa9cdf44687a3777adf7751ad39

    Find It @ SCU Libraries View record from DOAJ
    HTML Full Text     PDF Full Text
    Save to List
  7. 7
    Academic Journal

    First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

    Authors: Aida Piedra, Sergio Martínez-Recio, Ainhoa Hernández, Teresa Morán, Edurne Arriola, Jordi Recuero-Borau, Manuel Cobo, Patricia Cordeiro, Joaquín Mosquera, Manuel Fernández, Rosario García-Campelo, Antonio Calles, Rosa Álvarez, María Zapata-García, Dolores Isla, Ana Callejo, Patricia Iranzo, Jorgina Serra-López, Andrés Barba, Ivana Sullivan, Enriqueta Felip, Margarita Majem

    Source: Frontiers in Oncology, Vol 14 (2024)

    Subject Terms: pembrolizumab, non-small cell lung cancer, first-line, predictive factors, high PD-L1 expression, immune check-point inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1510278/full; https://doaj.org/toc/2234-943X

    Access URL: https://doaj.org/article/5bddfd2fdb244305bbfcb2496d8d7880

    Find It @ SCU Libraries View record from DOAJ
    Save to List
  8. 8
    Academic Journal

    Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

    Authors: Alexandra Leary, Purificación Estévez-García, Renaud Sabatier, Isabelle Ray-Coquard, Margarita Romeo, Pilar Barretina-Ginesta, Marta Gil-Martin, Elena Garralda, Joaquim Bosch-Barrera, Teresa Morán, Paloma Martin-Martorell, Ernest Nadal, Pere Gascón, Jordi Rodon, Jose M Lizcano, Pau Muñoz-Guardiola, Gemma Fierro-Durán, Oriol Pedrós-Gámez, Héctor Pérez-Montoyo, Marc Yeste-Velasco, Marc Cortal, Antonio Pérez-Campos, Jose Alfon, Carles Domenech, Alejandro Pérez-Fidalgo, Ana Oaknin

    Source: BMC Cancer, Vol 24, Iss 1, Pp 1-2 (2024)

    Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    Access URL: https://doaj.org/article/89e1d4a9c33c48d7a1f7222dc8a7a449

    Find It @ SCU Libraries View record from DOAJ
    Save to List
  9. 9
    Academic Journal

    Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?

    Authors: Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu, Teresa Morán, Anabel Mañes, Marc Cucurull, Carlos Martínez-Barenys, Iris Teruel, Gloria Moragas, Enric Carcereny, Ana Maria Muñoz Mármol, Maria Saigí

    Source: Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 6, Pp 1182-1187 (2023)

    Subject Terms: lung adenocarcinoma, epidermal growth factor receptor, oligoprogression, targeted therapy, epidermal growth factor receptor-tyrosine kinase inhibitors, Internal medicine, RC31-1245

    File Description: electronic resource

    Relation: https://www.explorationpub.com/Journals/etat/Article/1002191; https://doaj.org/toc/2692-3114

    Access URL: https://doaj.org/article/548b16587d6e4b5780c5798654aef425

    Find It @ SCU Libraries View record from DOAJ
    Save to List
  10. 10
    Academic Journal

    This result is not displayed to guests.

    Save to List
  11. 11
    Academic Journal

    This result is not displayed to guests.

    Save to List
  12. 12
    Academic Journal

    This result is not displayed to guests.

    Save to List
  13. 13
    Academic Journal

    This result is not displayed to guests.

    Save to List
  14. 14
    Academic Journal

    This result is not displayed to guests.

    Save to List
  15. 15
    Academic Journal

    This result is not displayed to guests.

    Save to List
  16. 16
    Academic Journal

    This result is not displayed to guests.

    Save to List
  17. 17
    Academic Journal

    This result is not displayed to guests.

    Save to List
  18. 18
    Academic Journal

    This result is not displayed to guests.

    Save to List
  19. 19
    Academic Journal

    Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

    Authors: Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip

    Source: Molecular Oncology, Vol 17, Iss 5, Pp 779-791 (2023)

    Subject Terms: aneuploidy, cfDNA, immune checkpoint inhibitors, liquid biopsy, NSCLC, shallow whole‐genome sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

    Access URL: https://doaj.org/article/604e6cdc2d234a06b5347b1a01ff2632

    Find It @ SCU Libraries View record from DOAJ
    Linked Full Text
    Save to List
  20. 20
    Academic Journal

    Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors

    Authors: Eudald Felip, Edwards Pradenas, Margarita Romeo, Silvia Marfil, Benjamin Trinité, Víctor Urrea, Ainhoa Hernández, Ester Ballana, Marc Cucurull, Lourdes Mateu, Marta Massanella, Bonaventura Clotet, Teresa Morán, Julià Blanco

    Source: Molecular Oncology, Vol 17, Iss 4, Pp 686-694 (2023)

    Subject Terms: adverse reactions, anticancer therapy, cancer, COVID‐19, moderna vaccine, neutralizing antibodies, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    File Description: electronic resource

    Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

    Access URL: https://doaj.org/article/cb23f6b2bc0042d091babfcdf72a34a2

    Find It @ SCU Libraries View record from DOAJ
    Linked Full Text
    Save to List

Search Tools: